Abbott approves $3 billion share buyback

SHARE Abbott approves $3 billion share buyback

Abbott Laboratories said Thursday its board approved spending up to $3 billion to buy back the health conglomerate’s stock.

The company, which makes Similac infant formula, medical devices and pharmaceutical drugs, said it will by stock from time to time depending on market conditions. It still has buyback authority to repurchase $511 million in shares from a buyback it announced in June 2013.

North Chicago-based Abbott also approved a dividend of 22 cents that will be paid on Nov. 15 to shareholders of record as of Oct. 15.

Abbott shares slipped 39 cents to $42.51 in afternoon trading Thursday. Its shares had risen more than 22 percent over the past year.

Abbott raises profit outlook

Abbott sells part of generic drugs business to Mylan for $5.3B

Abbott, Fonterra team up on China dairy farm


The Latest
Police couldn’t confirm if the incidents were related to each other, but said there was an increased number of officers in the area following Chicago’s first pride parade since 2019.
The woman, 24, swung a knife during a fight and stabbed three people in the 1000 block of West Belmont Avenue about 11:25 p.m., police said.
The driver, an 89-year-old woman, was among those who were hurt.
The woman, 22, was in a fight in the 5300 block of South Carpenter Street when she was stabbed in the chest and arms, police said.
The sergeant was attempting to arrest a male in the 3300 block of North Clark Street about 8:35 p.m. when he was punched in the head by a 21-year-old woman.